Lantheus Holdings (LNTH) Stock Price, Quote, News & History

Comments

Lantheus Holdings Inc (LNTH) Stock Price, Quote, News & History

LNTHNASDAQ

Trade with Public

$80.66

0.200.25%

Last update: Mar 18, 11:16 AM

OverviewNews Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

$79.75

Close

-

Volume / Avg.

133.07K / 967.90K

Day Range

$79.65 - $80.73

52 Wk Range

47.25 - 108.91

Market Cap

$5.35B

P/E Ratio

23.59

Dividend Yield

-

Exchange

NASDAQ

RSI

62

Short Interest

10.1%

Days to Cover

5.18

Recent Lantheus Holdings Inc News

PRO
CORRECTION: Lanthius Announces Three-Month Extension Of FDA's PDUFA Review Period To June 29 For Its LNTH-2501 Radioactive Diagnostic Kit

Benzinga Newsdesk

PRO
Lanthia Announces Three-Month Extension Of FDA's PDUFA Review Period To June 29 For Its LNTH-2501 Radioactive Diagnostic Kit

Benzinga Newsdesk

PRO
Lantheus Holdings shares are trading higher after the company announced that the FDA has approved its PYLARIFY TruVu injection, a new formulation of its F 18 prostate-specific membrane antigen imaging agent.

Benzinga Newsdesk

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

390.14M

Investing Cash Flow (TTM)

-627.17M

Financing Cash Flow (TTM)

-316.58M

Free Cash Flow (TTM)

348.64M

Capital Expenditure (TTM)

-41.50M

Net Change in Cash (TTM)

-553.61M

Analyst Trends and Forecast

1

Oct 25

0

Nov 25

3

Dec 25

1

Feb

1

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$5.46B

PE Ratio (TTM)

23.59

PE Ratio (FWD)

14.90

PEG Ratio (TTM)

-

PS Ratio (TTM)

3.57

PB Ratio (TTM)

4.77

Earnings Yield % (TTM)

4.24%

Earnings Yield % (FWD)

6.71%

EV / EBITDA (TTM)

13.52

Price / EBITDA (TTM)

13.64

Price / Free Cash Flow (TTM)

15.79

Book Value / Share

$16.87

Company Debt

Total Debt

$569.42M

LT Debt

$568.68M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$1.11M

Total Cash

$359.12M

Debt to Equity

0.57

Issuance of Debt (TTM)

-$1.11M

Repayment of Debt (TTM)

-$1.11M

Key Statistics

Open

$79.75

Close

-

Volume / Avg.

133.07K / 967.90K

Day Range

$79.65 - $80.73

52 Wk Range

47.25 - 108.91

Market Cap

$5.35B

P/E Ratio

23.59

Dividend Yield

-

Exchange

NASDAQ

RSI

62

Short Interest

10.1%

Days to Cover

5.18

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostic...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Lantheus Holdings (LNTH) stock?

A

You can purchase shares of Lantheus Holdings (NASDAQ:LNTH) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Lantheus Holdings (LNTH) competitors?

A

Other companies in Lantheus Holdings’s space includes: Solventum Corp (NYSE:SOLV), RxSight Inc (NASDAQ:RXST), Embecta Corp (NASDAQ:EMBC), Align Technology Inc (NASDAQ:ALGN) and ICU Medical Inc (NASDAQ:ICUI).

Q

What is the forecast, or price target, for Lantheus Holdings (LNTH) stock?

A

Lantheus Holdings has a consensus price target of $97.73.

Q

What is the current price for Lantheus Holdings (LNTH)?

A

The stock price for Lantheus Holdings (NASDAQ: LNTH) is $80.655 last updated March 18, 2026 at 11:16 AM EDT.

Q

Does Lantheus Holdings (LNTH) pay a dividend?

A

There are no upcoming dividends for Lantheus Holdings.

Q

When is Lantheus Holdings (NASDAQ:LNTH) reporting earnings?

A

Lantheus Holdings does not have any upcoming earnings scheduled.

Q

Is Lantheus Holdings (LNTH) going to split?

A

There is no upcoming split for Lantheus Holdings.

Q

What sector and industry does Lantheus Holdings (LNTH) operate in?

A

Lantheus Holdings is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.

People Also Watch

Utah Medical Products Inc

NASDAQ:UTMD

$64.11

0.09%

Merit Medical Systems Inc

NASDAQ:MMSI

$68.90

-1.89%

Key Statistics

Open

$79.75

Close

-

Volume / Avg.

133.07K / 967.90K

Day Range

$79.65 - $80.73

52 Wk Range

47.25 - 108.91

Market Cap

$5.35B

P/E Ratio

23.59

Dividend Yield

-

Exchange

NASDAQ

RSI

62

Short Interest

10.1%

Days to Cover

5.18

Recent Lantheus Holdings Inc News

PRO
CORRECTION: Lanthius Announces Three-Month Extension Of FDA's PDUFA Review Period To June 29 For Its LNTH-2501 Radioactive Diagnostic Kit

Benzinga Newsdesk

PRO
Lanthia Announces Three-Month Extension Of FDA's PDUFA Review Period To June 29 For Its LNTH-2501 Radioactive Diagnostic Kit

Benzinga Newsdesk

PRO
Lantheus Holdings shares are trading higher after the company announced that the FDA has approved its PYLARIFY TruVu injection, a new formulation of its F 18 prostate-specific membrane antigen imaging agent.

Benzinga Newsdesk

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

390.14M

Investing Cash Flow (TTM)

-627.17M

Financing Cash Flow (TTM)

-316.58M

Free Cash Flow (TTM)

348.64M

Capital Expenditure (TTM)

-41.50M

Net Change in Cash (TTM)

-553.61M

Analyst Trends and Forecast

1

Oct 25

0

Nov 25

3

Dec 25

1

Feb

1

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$5.46B

PE Ratio (TTM)

23.59

PE Ratio (FWD)

14.90

PEG Ratio (TTM)

-

PS Ratio (TTM)

3.57

PB Ratio (TTM)

4.77

Earnings Yield % (TTM)

4.24%

Earnings Yield % (FWD)

6.71%

EV / EBITDA (TTM)

13.52

Price / EBITDA (TTM)

13.64

Price / Free Cash Flow (TTM)

15.79

Book Value / Share

$16.87

Company Debt

Total Debt

$569.42M

LT Debt

$568.68M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$1.11M

Total Cash

$359.12M

Debt to Equity

0.57

Issuance of Debt (TTM)

-$1.11M

Repayment of Debt (TTM)

-$1.11M

Key Statistics

Open

$79.75

Close

-

Volume / Avg.

133.07K / 967.90K

Day Range

$79.65 - $80.73

52 Wk Range

47.25 - 108.91

Market Cap

$5.35B

P/E Ratio

23.59

Dividend Yield

-

Exchange

NASDAQ

RSI

62

Short Interest

10.1%

Days to Cover

5.18

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostic...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry